Price $136.82 |
Market Cap
7.25B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.6
|
P/B
2.63
|
P/S
3.67
|
Dividend %
-
|
|
P/CF
73.7
|
P/FCF
9.3
|
Op. Cash Flow
833.8K
|
FCF
13.4
|
|
Op. Margin
33.70%
|
Net Margin
24.90%
|
ROE
17.10%
|
ROI
12.20%
|
|
ROA
9.10%
|
EPS Growth
9.80%
|
Current Ratio
3.6
|
Debt/Equity
56.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cocrystal Pharma Inc (COCP) | $2.35 | - | - | 74.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.93 | - | - | 87.4M | Strong Buy |
| Hologic, Inc. (HOLX) | $47.55 | - | - | 11.78B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.54 | - | - | 44.5M | Strong Buy |
| Lannett Company, Inc. (LCI) | $5.90 | - | - | 215.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
